This page provides links to a selection of upcoming calls from the Horizon Europe and other European programmes. These have been selected by the ESE Science Committee as calls that are likely to have relevance to endocrinologists.
Horizon Europe Workprogramme 2026 – 2027
European Commission has recently published updates for several parts of Horizon Europe Workprogramme for 2026–2027 - please see below information about calls and deadlines.
Ten single-stage topics have a complete-proposal deadline of 17 February 2027. For four two-stage topics, that is the first-stage deadline, with the second stage due on 16 September 2027.
Additionally, there will be three one-stage calls with deadline on 16 September 2027.
Please see below list of calls with deadlines:
- Ten one-stage calls (deadline 17 February 2027)
|
HORIZON-HLTH-2027-01-STAYHLTH-01: Addressing disabilities through the life course to support independent living and inclusion |
|
HORIZON-HLTH-2027-01-ENVHLTH-02: Integrating climate-related exposures into the human exposome and characterising its changes in response to climate change |
|
HORIZON-HLTH-2027-01-ENVHLTH-MISSCLIMA-03: Tools and technologies to support health adaptation to climate change |
|
HORIZON-HLTH-2027-01-DISEASE-05: Development of novel small molecule antiviral therapeutics for pathogens with epidemic potential |
|
HORIZON-HLTH-2027-01-DISEASE-06: Development of monoclonal antibodies to prevent and treat infections from Flaviviruses |
|
HORIZON-HLTH-2027-01-DISEASE-07: Development of monoclonal antibodies to prevent and treat infections from Filo-, Nairo-, Phenui-, Picorna- and Toga viruses |
|
HORIZON-HLTH-2027-01-DISEASE-08: Development of innovative antimicrobials against pathogens resistant to antimicrobials |
|
HORIZON-HLTH-2027-01-DISEASE-10: Prevention and management of chronic non-communicable diseases in children and young people (GACD) |
|
HORIZON-HLTH-2027-01-CARE-02: Personalised approaches to reduce risks from Adverse Drug Reactions due to administration of multiple medications |
|
HORIZON-HLTH-2027-01-IND-01: Development of cell-free protein synthesis platforms for discovery and/or production of biologicals |
- Two stage calls deadlines: 17 February 2027 (first stage), 16 September 2027 (second stage)
|
HORIZON-HLTH-2027-02-DISEASE-01-two-stage: Innovative healthcare interventions for non-communicable diseases |
|
HORIZON-HLTH-2027-02-DISEASE-14-two-stage: Clinical trials for advancing innovative interventions for neurodegenerative diseases |
|
HORIZON-HLTH-2027-02-TOOL-01-two-stage: Development of predictive biomarkers of disease progression and treatment response by using AI methodologies for chronic non-communicable diseases |
|
HORIZON-HLTH-2027-02-IND-02-two-stage: Portable and versatile Point-of-care diagnostics |
- Three one-stage calls have deadlines on 16 September 2027
|
- HORIZON-HLTH-2027-03-TOOL-02: Advancing bio-printing of living cells for regenerative medicine |
|
- HORIZON-HLTH-2027-03-TOOL-04: Virtual Human Twins (VHTs) for integrated clinical decision support in prevention and diagnosis |
|
- HORIZON-HLTH-2027-03-TOOL-08: Towards the next generation of frontier Artificial Intelligence models for healthcare |
For more information please consult updates Workprogramme 2026 – 2027 Cluster 1 Health
24–25 November 2026 Cluster Health brokerage event, followed by an information day on 26 November 2026.
More information on brokerage event : https://www.b2match.com/e/cluster-health-horizon-europe-brokerage-2027
Please note: The event is free of charge, but registration and profile activation are mandatory to attend the brokerage event.
Cluster 1 Health info day: https://hadea.ec.europa.eu/events/horizon-europe-info-days-cluster-1-health-2026-11-26_en
Opening date is 10 February 2027 and the final submission deadline is 21 September 2027
|
HORIZON-MISS-2027-02-CANCER-01: |
|
HORIZON-MISS-2027-02-CANCER-02: Clinical research by Comprehensive Cancer Infrastructures for the benefit of patients with common cancers |
|
HORIZON-MISS-2027-02-CANCER-03: |
|
HORIZON-MISS-2027-02-CANCER-04: Improving equitable health outcomes and added value for and with cancer patients through health-economics research, health systems research and outcomes research |
|
HORIZON-MISS-2027-02-CANCER-05: Pre-commercial procurement of affordable solutions for healthcare systems in the areas of cancer technologies, cancer medical devices, or cancer medicines |
|
HORIZON-MISS-2027-02-CANCER-06: Support a Young Cancer Survivor Quality of Life (QoL) research programme by cancer charities and funding agencies |
For more information please consult Missions Workprogramme 2026 - 2027 (page 88 onwards).
|
Call |
Opening |
Deadline |
|
MSCA Staff Exchanges |
15 December 2026 |
15 April 2027 |
|
MSCA Postdoctoral fellowships |
7 April 2027 | 8 September 2027 |
|
MSCA Doctoral Networks |
28 May 2026 |
24 Nov 2026 |
|
26 May 2027 |
23 Nov 2027 |
|
|
MSCA COFUND |
8 Dec 2026 |
6 April 2027 |
|
MSCA and Citizens 2027 |
To be confirmed |
8 June 2027 |
|
MSCA Choose Europe for Science 2027 |
8 Dec 2026 |
6 April 2027 |
Note: MSCA Choose Europe for Science is a pilot initiative under the European Union's Marie Skłodowska-Curie Actions (MSCA) designed to increase the attractiveness of European research careers by reducing job precarity and combating brain drain. Unlike traditional research grants that only offer short-term funding, this scheme selects and funds host organisations based on their ability to offer longer-term employment perspectives and excellent working conditions for researchers.
For more information please consult MSCA Workprogramme 2026 – 2027
|
Grant Type |
Call ID |
Opening Date |
Closing Deadline |
|
Consolidator Grants |
ERC-2027-CoG |
24 September 2026 |
12 January 2027 |
|
Synergy Grants |
ERC-2027-SyG |
17 February 2027 |
11 May 2027 |
|
Advanced Grants |
ERC-2027-AdG |
27 May 2027 |
26 August 2027 |
|
ERC Plus Grant |
ERC-2027-PLUS |
1 June 2027 |
1 September 2027 |
*ERC Plus Grant is a new European Research Council initiative providing up to €7 million over 4–7 years for high-risk, transformative, and "breakthrough-oriented" research that exceeds the scope of standard ERC grants. These highly competitive, once-in-a-lifetime, one-time grants are aimed at pioneering projects from researchers of any career stage.
For more information please consult ERC workprogramme 2027
EIC Pathfinder programs fund early-stage scientific discovery, proof-of-principle validation, and moving lab results toward commercial maturity.
New draft EIC Workprogramme 2027 has been published.
What is new: Pathfinder Open splits into two stages (short & full application) and adds an interview for every above-threshold proposal.
Deadlines for EIC Pathfinder Open are: Stage 1 – 25/02/2027; Stage 2 –16/09/2027
Deadline for EIC Pathfinder Challenges is 29/09/27 and challenges are as following:
- Breakthroughs in Advanced Materials for Electricity Generation, Storage and Transmission
- Safe and Controlled Continual Learning in Open World for Reliable AI Agents (CLOWAI)
- Quantum Energetics
The following topics are under consideration for inclusion in IHI calls 14 and 15, which are planned to be launched in early 2027. These will be the last calls launched under the current programme.
IHI call 14 draft topic texts
- Topic 1: Validation of human-relevant novel approaches to accelerate the discovery and pre-clinical development of innovative medicinal products and health technologies
- Topic 2: Validated, predictive approaches for clinical development of innovative personalised health technologies
- Topic 3: Transforming healthcare delivery through integrated, scalable and patient-centred care systems
- Topic 4: Advanced therapy medicinal products: Supporting manufacturing and clinical centre readiness in Europe
IHI call 15 draft topic texts
- Topic 1: A common European approach to equitable patient access to compassionate use
- Topic 2: From early endpoints to long-term outcomes: Healthcare decision-making on the use of surrogate evidence for timely patient access
The topics are currently under consultation with several stakeholders . They may therefore change considerably between the versions published here and the call launch, and applicants should check the final, approved topic texts once they are published at IHI website.